Skip to main content

Table 7 Adverse events observed among groups B, C and D

From: Adjuvant chemotherapy is an additional option for locally advanced gastric cancer after radical gastrectomy with D2 lymphadenectomy: a retrospective control study

Adverse event Grade 3 or 4, n (%) p
group B (n = 165) group C (n = 99) group D (n = 57) total (n = 321)
Nausea/Vomiting 26 (15.8) 16 (16.2) 10 (17.5) 52 (16.2) 0.951
Neutropenia 33 (20.0) 19 (19.2) 8 (14.0) 60 (18.7) 0.602
Thrombocytopenia 10 (6.1) 8 (8.1) 3 (5.3) 21 (6.5) 0.985